Table 1.
Demographics, HIV disease characteristics, and VACS components (n = 45).
| Variable | |
|---|---|
| Age, yrs | 65.0 (62.0, 66.0) |
| Gender (male) | 41, 91.1% |
| Ethnicity (caucasian) | 39, 86.7% |
| EDI, yrs | 25.3 (23.0, 30) |
| HIV RNA <50 copies/mL | 45, 100% |
| BMIa | 26.5 (24.4, 28.4) |
| CD4 Nadir (cells/μL)a | 173 (50, 243) |
| Current CD4 (cells/μL)b | 623 (403, 804) |
| ≥500 | 28, 65.1% |
| 350–499 | 9, 20.9% |
| 200–349 | 6, 13.0% |
| <200 | 1, 2.0% |
| Hemoglobin (g/dL)b | 14.8 (14.2, 15.8) |
| FIB-4a | 1.8 (1.2, 2.0) |
| <1.45 | 16, 36.4% |
| 1.45–3.25 | 25, 56.8% |
| >3.25 | 3, 6.8% |
| eGFRa | 73.7 (60.3, 87.2) |
| ≥60 | 34, 77.3% |
| 30–59.9 | 10, 22.7% |
| HCV infection | 7, 15.6% |
| VACS index scorec | 30 (18, 39) |
Continuous variables are listed as mean (Q1, Q3) and categorical variables as n, %. EDI, estimated duration of infection; BMI, body mass index; FIB-4, fibrosis index 4; eGFR, estimated glomerular filtration rate; HCV, Hepatitis C virus.
a
n = 36,
b
n = 44,
c
n = 43.